Rokos Capital Management LLP Eq Rx, Inc. Transaction History

Rokos Capital Management LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.8 - $2.83 $4.1 Million - $6.45 Million	2,278,128 Added 17.44%	15,342,566 $29.8 Million
Q4 2022 Feb 14, 2023	BUY	$2.05 - $5.5 $16.1 Million - $43.3 Million	7,868,044 Added 151.41%	13,064,438 $32.1 Million
Q2 2022 Aug 15, 2022	BUY	$3.2 - $5.69 $9.11 Million - $16.2 Million	2,848,028 Added 121.28%	5,196,394 $24.1 Million
Q1 2022 May 16, 2022	BUY	$2.8 - $7.39 $6.58 Million - $17.4 Million	2,348,366 New	2,348,366 $9.91 Million

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Rokos Capital Management LLP, based on Form 13F filings with the SEC.

Stay updated on Rokos Capital Management LLP with notifications on news.